Smith Group Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-42,700	Closed	-$5.14M	–	162
2024 Q1	$5.14M	Sell	42,700 -20,270	-32%	-$2.48M	0.29%	78
2023 Q4	$7.75M	Buy	+62,970	New	+$7.86M	0.45%	71
2020 Q2	–	Sell	-79,360	Closed	-$7.92M	–	331
2020 Q1	$7.92M	Sell	79,360 -19,440	-20%	-$2.51M	0.43%	61
2019 Q4	$14.7M	Sell	98,800 -52,700	-35%	-$7.17M	0.62%	58
2019 Q3	$19.4M	Sell	151,500 -2,470	-2%	-$331K	0.68%	59
2019 Q2	$21.9M	Buy	+153,970	New	+$20.7M	0.74%	53
2014 Q2	–	Sell	-87,000	Closed	-$12.1M	–	432
2014 Q1	$12.1M	Buy	+87,000	New	+$13.1M	0.46%	78
2013 Q4	–	Sell	-50,176	Closed	-$4.62M	–	413
2013 Q3	$4.62M	Sell	50,176 -12,876	-20%	-$1.04M	0.19%	93
2013 Q2	$4.33M	Buy	+63,052	New	+$3.85M	0.19%	105